Sera Prognostics, Inc. (SERA)
2.01
+0.03
(+1.52%)
USD |
NASDAQ |
Nov 13, 16:00
2.00
-0.01
(-0.50%)
After-Hours: 19:59
Sera Prognostics Enterprise Value : 39.06M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 39.06M |
| November 12, 2026 | 37.87M |
| November 11, 2026 | 36.28M |
| November 10, 2026 | 38.27M |
| November 09, 2026 | 46.22M |
| November 06, 2026 | 46.22M |
| November 05, 2026 | 41.84M |
| November 04, 2026 | 39.26M |
| November 03, 2026 | 35.88M |
| November 02, 2026 | 38.27M |
| October 30, 2026 | 40.26M |
| October 29, 2026 | 41.05M |
| October 28, 2026 | 39.86M |
| October 27, 2026 | 40.65M |
| October 26, 2026 | 40.26M |
| October 23, 2026 | 39.86M |
| October 22, 2026 | 40.26M |
| October 21, 2026 | 39.86M |
| October 20, 2026 | 39.86M |
| October 19, 2026 | 39.86M |
| October 16, 2026 | 41.05M |
| October 15, 2026 | 39.86M |
| October 14, 2026 | 41.45M |
| October 13, 2026 | 40.26M |
| October 12, 2026 | 41.45M |
| Date | Value |
|---|---|
| October 09, 2026 | 40.26M |
| October 08, 2026 | 39.46M |
| October 07, 2026 | 41.45M |
| October 06, 2026 | 40.65M |
| October 05, 2026 | 38.67M |
| October 02, 2026 | 42.24M |
| October 01, 2026 | 40.26M |
| September 30, 2026 | 42.24M |
| September 29, 2026 | 35.83M |
| September 28, 2026 | 36.22M |
| September 25, 2026 | 37.01M |
| September 24, 2026 | 39.77M |
| September 23, 2026 | 37.80M |
| September 22, 2026 | 40.56M |
| September 21, 2026 | 40.16M |
| September 18, 2026 | 38.78M |
| September 17, 2026 | 38.19M |
| September 16, 2026 | 36.22M |
| September 15, 2026 | 35.04M |
| September 14, 2026 | 35.43M |
| September 11, 2026 | 36.62M |
| September 10, 2026 | 37.40M |
| September 09, 2026 | 35.43M |
| September 08, 2026 | 35.83M |
| September 04, 2026 | 36.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 643.96M |
| BioRestorative Therapies, Inc. | -1.659M |
| CareDx, Inc. | 3.864B |
| Natera, Inc. | 45.20B |
| Exagen, Inc. | 105.65M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.053M |
| Revenue (Quarterly) | 0.042M |
| Total Expenses (Quarterly) | 8.095M |
| EPS Diluted (Quarterly) | -0.1586 |
| Gross Profit Margin (Quarterly) | -433.3% |
| Profit Margin (Quarterly) | -19.17K% |
| Earnings Yield | -33.05% |
| Normalized Earnings Yield | -33.05 |